nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA6—saliva—conduct disorder	0.186	0.304	CbGeAlD
Imatinib—ORM1—saliva—conduct disorder	0.0989	0.162	CbGeAlD
Imatinib—HIPK4—brain—conduct disorder	0.0324	0.0529	CbGeAlD
Imatinib—ABCA3—brain—conduct disorder	0.032	0.0523	CbGeAlD
Imatinib—DDR1—brain—conduct disorder	0.0295	0.0483	CbGeAlD
Imatinib—ABL2—brain—conduct disorder	0.0193	0.0315	CbGeAlD
Imatinib—CA7—brain—conduct disorder	0.019	0.031	CbGeAlD
Imatinib—PIP4K2C—brain—conduct disorder	0.0182	0.0298	CbGeAlD
Imatinib—CA3—brain—conduct disorder	0.0174	0.0285	CbGeAlD
Imatinib—CA14—brain—conduct disorder	0.0158	0.0259	CbGeAlD
Imatinib—NQO2—brain—conduct disorder	0.0134	0.0219	CbGeAlD
Imatinib—PDGFRA—brain—conduct disorder	0.0134	0.0218	CbGeAlD
Imatinib—CA12—brain—conduct disorder	0.0123	0.0202	CbGeAlD
Imatinib—CSF1R—brain—conduct disorder	0.0118	0.0192	CbGeAlD
Imatinib—SLC47A1—brain—conduct disorder	0.0107	0.0176	CbGeAlD
Imatinib—KIT—brain—conduct disorder	0.0107	0.0175	CbGeAlD
Imatinib—PDGFRB—brain—conduct disorder	0.0104	0.0171	CbGeAlD
Imatinib—CA1—brain—conduct disorder	0.00977	0.016	CbGeAlD
Imatinib—ABL1—brain—conduct disorder	0.0093	0.0152	CbGeAlD
Imatinib—SLC22A1—brain—conduct disorder	0.00896	0.0147	CbGeAlD
Imatinib—ALB—brain—conduct disorder	0.00858	0.014	CbGeAlD
Imatinib—CA2—brain—conduct disorder	0.00633	0.0104	CbGeAlD
Imatinib—ABCG2—brain—conduct disorder	0.00586	0.00959	CbGeAlD
Imatinib—PTGS1—brain—conduct disorder	0.00489	0.008	CbGeAlD
Imatinib—CYP2D6—brain—conduct disorder	0.00402	0.00657	CbGeAlD
Imatinib—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00316	0.00814	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—DRD4—conduct disorder	0.00312	0.00803	CbGpPWpGaD
Imatinib—CA3—Metabolism—CGA—conduct disorder	0.00296	0.00763	CbGpPWpGaD
Imatinib—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.00291	0.00748	CbGpPWpGaD
Imatinib—ABCB1—brain—conduct disorder	0.00289	0.00473	CbGeAlD
Imatinib—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.0028	0.00722	CbGpPWpGaD
Imatinib—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00256	0.0066	CbGpPWpGaD
Imatinib—CA9—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00253	0.0065	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00252	0.00649	CbGpPWpGaD
Imatinib—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00248	0.0064	CbGpPWpGaD
Imatinib—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00246	0.00634	CbGpPWpGaD
Imatinib—CA1—C-MYB transcription factor network—EP300—conduct disorder	0.00237	0.0061	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00235	0.00605	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—MB21D1—conduct disorder	0.00228	0.00586	CbGpPWpGaD
Imatinib—NTRK1—p73 transcription factor network—EP300—conduct disorder	0.00228	0.00586	CbGpPWpGaD
Imatinib—ABCG2—HIF-2-alpha transcription factor network—EP300—conduct disorder	0.00217	0.00559	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—MB21D1—conduct disorder	0.00215	0.00555	CbGpPWpGaD
Imatinib—KIT—Kit receptor signaling pathway—EP300—conduct disorder	0.00211	0.00542	CbGpPWpGaD
Imatinib—PDGFRA—ATF-2 transcription factor network—EP300—conduct disorder	0.00199	0.00513	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—MB21D1—conduct disorder	0.00194	0.005	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—GABRA2—conduct disorder	0.00193	0.00497	CbGpPWpGaD
Imatinib—CA14—Metabolism—CGA—conduct disorder	0.00191	0.00492	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—MB21D1—conduct disorder	0.00189	0.00487	CbGpPWpGaD
Imatinib—ABL1—Validated transcriptional targets of TAp63 isoforms—EP300—conduct disorder	0.00188	0.00484	CbGpPWpGaD
Imatinib—CA6—Metabolism—CGA—conduct disorder	0.00186	0.00479	CbGpPWpGaD
Imatinib—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00185	0.00477	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—GABRA2—conduct disorder	0.0018	0.00463	CbGpPWpGaD
Imatinib—ABL1—p53 pathway—EP300—conduct disorder	0.00175	0.00451	CbGpPWpGaD
Imatinib—CA7—Metabolism—CGA—conduct disorder	0.00174	0.00447	CbGpPWpGaD
Imatinib—PDGFRB—Validated targets of C-MYC transcriptional repression—EP300—conduct disorder	0.0017	0.00439	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—POLR3A—conduct disorder	0.00167	0.0043	CbGpPWpGaD
Imatinib—CA12—Metabolism—CGA—conduct disorder	0.00161	0.00414	CbGpPWpGaD
Imatinib—ABL1—Regulation of retinoblastoma protein—EP300—conduct disorder	0.0016	0.00412	CbGpPWpGaD
Imatinib—KIT—C-MYB transcription factor network—EP300—conduct disorder	0.00159	0.00409	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—POLR3A—conduct disorder	0.00158	0.00407	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—MB21D1—conduct disorder	0.00156	0.00401	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00153	0.00394	CbGpPWpGaD
Imatinib—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00143	0.00369	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—POLR3A—conduct disorder	0.00142	0.00367	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—WASF1—conduct disorder	0.00141	0.00362	CbGpPWpGaD
Imatinib—LCK—Notch Signaling Pathway—EP300—conduct disorder	0.0014	0.00361	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—POLR3A—conduct disorder	0.00139	0.00358	CbGpPWpGaD
Imatinib—ABL1—p73 transcription factor network—EP300—conduct disorder	0.00139	0.00357	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways in Glioblastoma—EP300—conduct disorder	0.00138	0.00355	CbGpPWpGaD
Imatinib—CYP3A7—Biological oxidations—COMT—conduct disorder	0.00137	0.00353	CbGpPWpGaD
Imatinib—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.00136	0.0035	CbGpPWpGaD
Imatinib—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00135	0.00348	CbGpPWpGaD
Imatinib—CA3—Metabolism—COMT—conduct disorder	0.00134	0.00344	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—WASF1—conduct disorder	0.00133	0.00343	CbGpPWpGaD
Imatinib—PTGS1—Biological oxidations—COMT—conduct disorder	0.00133	0.00342	CbGpPWpGaD
Imatinib—CA3—Metabolism—MAOA—conduct disorder	0.00133	0.00342	CbGpPWpGaD
Imatinib—KIT—Immune System—MB21D1—conduct disorder	0.00133	0.00341	CbGpPWpGaD
Imatinib—PTGS1—Biological oxidations—MAOA—conduct disorder	0.00132	0.0034	CbGpPWpGaD
Imatinib—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00132	0.00339	CbGpPWpGaD
Imatinib—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00131	0.00336	CbGpPWpGaD
Imatinib—ABCG2—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00128	0.00329	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—MB21D1—conduct disorder	0.00126	0.00323	CbGpPWpGaD
Imatinib—CA2—Metabolism—CGA—conduct disorder	0.00123	0.00317	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00121	0.00312	CbGpPWpGaD
Imatinib—SLC22A2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0012	0.0031	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—WASF1—conduct disorder	0.0012	0.00309	CbGpPWpGaD
Imatinib—CA1—Metabolism—CGA—conduct disorder	0.00118	0.00304	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—WASF1—conduct disorder	0.00117	0.00301	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—POLR3A—conduct disorder	0.00114	0.00294	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00113	0.00291	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MB21D1—conduct disorder	0.00113	0.00291	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00113	0.00291	CbGpPWpGaD
Imatinib—ABL1—Cell Cycle—EP300—conduct disorder	0.00113	0.00291	CbGpPWpGaD
Imatinib—SLC22A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00112	0.00289	CbGpPWpGaD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.00112	0.00289	CbGpPWpGaD
Imatinib—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00112	0.00287	CbGpPWpGaD
Imatinib—ABL1—Immune System—MB21D1—conduct disorder	0.0011	0.00284	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—EP300—conduct disorder	0.00108	0.00278	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00105	0.0027	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00104	0.00267	CbGpPWpGaD
Imatinib—CA9—Metabolism—CGA—conduct disorder	0.00104	0.00267	CbGpPWpGaD
Imatinib—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00102	0.00263	CbGpPWpGaD
Imatinib—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000991	0.00255	CbGpPWpGaD
Imatinib—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.000984	0.00253	CbGpPWpGaD
Imatinib—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000977	0.00252	CbGpPWpGaD
Imatinib—KIT—Immune System—POLR3A—conduct disorder	0.000973	0.00251	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000968	0.00249	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—WASF1—conduct disorder	0.000962	0.00248	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—COMT—conduct disorder	0.000929	0.00239	CbGpPWpGaD
Imatinib—SLC22A2—Neuronal System—MAOA—conduct disorder	0.000923	0.00238	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—POLR3A—conduct disorder	0.000921	0.00237	CbGpPWpGaD
Imatinib—LCK—Immune System—MB21D1—conduct disorder	0.000907	0.00234	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—EP300—conduct disorder	0.000905	0.00233	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CGA—conduct disorder	0.000902	0.00232	CbGpPWpGaD
Imatinib—ABL1—Factors involved in megakaryocyte development and platelet production—EP300—conduct disorder	0.000897	0.00231	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—COMT—conduct disorder	0.000866	0.00223	CbGpPWpGaD
Imatinib—CA14—Metabolism—COMT—conduct disorder	0.000862	0.00222	CbGpPWpGaD
Imatinib—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000861	0.00222	CbGpPWpGaD
Imatinib—SLC22A1—Neuronal System—MAOA—conduct disorder	0.00086	0.00222	CbGpPWpGaD
Imatinib—CA14—Metabolism—MAOA—conduct disorder	0.000856	0.0022	CbGpPWpGaD
Imatinib—CA6—Metabolism—COMT—conduct disorder	0.00084	0.00216	CbGpPWpGaD
Imatinib—CA6—Metabolism—MAOA—conduct disorder	0.000834	0.00215	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—EP300—conduct disorder	0.000833	0.00214	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—POLR3A—conduct disorder	0.00083	0.00214	CbGpPWpGaD
Imatinib—ABL1—Integrated Breast Cancer Pathway—EP300—conduct disorder	0.000825	0.00212	CbGpPWpGaD
Imatinib—KIT—Immune System—WASF1—conduct disorder	0.000819	0.00211	CbGpPWpGaD
Imatinib—ABL1—Immune System—POLR3A—conduct disorder	0.000809	0.00208	CbGpPWpGaD
Imatinib—CA7—Metabolism—COMT—conduct disorder	0.000784	0.00202	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000779	0.00201	CbGpPWpGaD
Imatinib—CA7—Metabolism—MAOA—conduct disorder	0.000778	0.002	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—WASF1—conduct disorder	0.000775	0.002	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000766	0.00197	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000761	0.00196	CbGpPWpGaD
Imatinib—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000756	0.00195	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000735	0.00189	CbGpPWpGaD
Imatinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000735	0.00189	CbGpPWpGaD
Imatinib—CA12—Metabolism—COMT—conduct disorder	0.000726	0.00187	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000726	0.00187	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—WASF1—conduct disorder	0.000723	0.00186	CbGpPWpGaD
Imatinib—CA12—Metabolism—MAOA—conduct disorder	0.000721	0.00186	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000705	0.00181	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.0007	0.0018	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—WASF1—conduct disorder	0.000699	0.0018	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000698	0.0018	CbGpPWpGaD
Imatinib—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000695	0.00179	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000694	0.00179	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.00069	0.00178	CbGpPWpGaD
Imatinib—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000689	0.00177	CbGpPWpGaD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000684	0.00176	CbGpPWpGaD
Imatinib—ABL1—Immune System—WASF1—conduct disorder	0.000681	0.00175	CbGpPWpGaD
Imatinib—LCK—Immune System—POLR3A—conduct disorder	0.000666	0.00171	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CGA—conduct disorder	0.000661	0.0017	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000652	0.00168	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000647	0.00167	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CGA—conduct disorder	0.000626	0.00161	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000597	0.00154	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000594	0.00153	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000593	0.00153	CbGpPWpGaD
Imatinib—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000589	0.00152	CbGpPWpGaD
Imatinib—CA3—Metabolism—EP300—conduct disorder	0.000573	0.00148	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000567	0.00146	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CGA—conduct disorder	0.000564	0.00145	CbGpPWpGaD
Imatinib—LCK—Immune System—WASF1—conduct disorder	0.000561	0.00144	CbGpPWpGaD
Imatinib—CA2—Metabolism—COMT—conduct disorder	0.000555	0.00143	CbGpPWpGaD
Imatinib—CA2—Metabolism—MAOA—conduct disorder	0.000551	0.00142	CbGpPWpGaD
Imatinib—CA1—Metabolism—COMT—conduct disorder	0.000532	0.00137	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—WASF1—conduct disorder	0.00053	0.00136	CbGpPWpGaD
Imatinib—CA1—Metabolism—MAOA—conduct disorder	0.000529	0.00136	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—CGA—conduct disorder	0.000524	0.00135	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—CGA—conduct disorder	0.000519	0.00134	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—CGA—conduct disorder	0.000519	0.00134	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000508	0.00131	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—DRD4—conduct disorder	0.000505	0.0013	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—CGA—conduct disorder	0.000503	0.0013	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—WASF1—conduct disorder	0.000501	0.00129	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—CGA—conduct disorder	0.000483	0.00124	CbGpPWpGaD
Imatinib—CA9—Metabolism—COMT—conduct disorder	0.000468	0.00121	CbGpPWpGaD
Imatinib—CA9—Metabolism—MAOA—conduct disorder	0.000465	0.0012	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000461	0.00119	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000457	0.00118	CbGpPWpGaD
Imatinib—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000454	0.00117	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CGA—conduct disorder	0.000452	0.00116	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—WASF1—conduct disorder	0.000452	0.00116	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CGA—conduct disorder	0.000375	0.000967	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—DRD4—conduct disorder	0.00037	0.000953	CbGpPWpGaD
Imatinib—CA14—Metabolism—EP300—conduct disorder	0.000369	0.000951	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—WASF1—conduct disorder	0.000362	0.000933	CbGpPWpGaD
Imatinib—CA6—Metabolism—EP300—conduct disorder	0.00036	0.000927	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—DRD4—conduct disorder	0.00035	0.000902	CbGpPWpGaD
Imatinib—KIT—Innate Immune System—EP300—conduct disorder	0.00034	0.000875	CbGpPWpGaD
Imatinib—CA7—Metabolism—EP300—conduct disorder	0.000336	0.000866	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HTR2A—conduct disorder	0.00033	0.000849	CbGpPWpGaD
Imatinib—ALB—Metabolism—CGA—conduct disorder	0.000323	0.000832	CbGpPWpGaD
Imatinib—PDGFRA—Innate Immune System—EP300—conduct disorder	0.000322	0.000828	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—EP300—conduct disorder	0.00032	0.000823	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—DRD4—conduct disorder	0.000316	0.000813	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—EP300—conduct disorder	0.000314	0.000807	CbGpPWpGaD
Imatinib—CA12—Metabolism—EP300—conduct disorder	0.000311	0.000802	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—conduct disorder	0.000295	0.000759	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CGA—conduct disorder	0.00029	0.000747	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—EP300—conduct disorder	0.00029	0.000746	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CGA—conduct disorder	0.000283	0.000729	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—EP300—conduct disorder	0.000282	0.000727	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CGA—conduct disorder	0.000267	0.000687	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CGA—conduct disorder	0.000265	0.000681	CbGpPWpGaD
Imatinib—LCK—Hemostasis—EP300—conduct disorder	0.000258	0.000665	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—DRD4—conduct disorder	0.000253	0.000652	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HTR2A—conduct disorder	0.000241	0.000622	CbGpPWpGaD
Imatinib—CA2—Metabolism—EP300—conduct disorder	0.000238	0.000613	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—COMT—conduct disorder	0.000237	0.000609	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MAOA—conduct disorder	0.000235	0.000605	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—COMT—conduct disorder	0.000234	0.000604	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—COMT—conduct disorder	0.000234	0.000603	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MAOA—conduct disorder	0.000233	0.000599	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—EP300—conduct disorder	0.000232	0.000599	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MAOA—conduct disorder	0.000232	0.000598	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HTR2A—conduct disorder	0.000229	0.000589	CbGpPWpGaD
Imatinib—CA1—Metabolism—EP300—conduct disorder	0.000228	0.000588	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—COMT—conduct disorder	0.000227	0.000585	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CGA—conduct disorder	0.000226	0.000582	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MAOA—conduct disorder	0.000226	0.000581	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000219	0.000563	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—COMT—conduct disorder	0.000218	0.000562	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MAOA—conduct disorder	0.000217	0.000558	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HTR2A—conduct disorder	0.000206	0.00053	CbGpPWpGaD
Imatinib—CA9—Metabolism—EP300—conduct disorder	0.000201	0.000517	CbGpPWpGaD
Imatinib—KIT—Immune System—EP300—conduct disorder	0.000198	0.000509	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—EP300—conduct disorder	0.000187	0.000482	CbGpPWpGaD
Imatinib—KIT—Disease—EP300—conduct disorder	0.000183	0.00047	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—EP300—conduct disorder	0.000175	0.00045	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CGA—conduct disorder	0.000175	0.000449	CbGpPWpGaD
Imatinib—PDGFRA—Disease—EP300—conduct disorder	0.000173	0.000445	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—COMT—conduct disorder	0.000169	0.000436	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—EP300—conduct disorder	0.000169	0.000434	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MAOA—conduct disorder	0.000168	0.000433	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HTR2A—conduct disorder	0.000165	0.000425	CbGpPWpGaD
Imatinib—ABL1—Immune System—EP300—conduct disorder	0.000164	0.000423	CbGpPWpGaD
Imatinib—PDGFRB—Disease—EP300—conduct disorder	0.000156	0.000401	CbGpPWpGaD
Imatinib—ALB—Hemostasis—EP300—conduct disorder	0.000154	0.000397	CbGpPWpGaD
Imatinib—ALB—Metabolism—COMT—conduct disorder	0.000146	0.000376	CbGpPWpGaD
Imatinib—ALB—Metabolism—MAOA—conduct disorder	0.000145	0.000373	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000141	0.000362	CbGpPWpGaD
Imatinib—LCK—Immune System—EP300—conduct disorder	0.000135	0.000349	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—COMT—conduct disorder	0.000131	0.000337	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MAOA—conduct disorder	0.00013	0.000335	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—EP300—conduct disorder	0.000128	0.000329	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—COMT—conduct disorder	0.000128	0.000329	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MAOA—conduct disorder	0.000127	0.000327	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000126	0.000325	CbGpPWpGaD
Imatinib—LCK—Disease—EP300—conduct disorder	0.000125	0.000322	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—EP300—conduct disorder	0.000121	0.000312	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—COMT—conduct disorder	0.00012	0.00031	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MAOA—conduct disorder	0.00012	0.000308	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—COMT—conduct disorder	0.000119	0.000308	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MAOA—conduct disorder	0.000119	0.000305	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000115	0.000296	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—EP300—conduct disorder	0.000109	0.000281	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—COMT—conduct disorder	0.000102	0.000263	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—EP300—conduct disorder	0.000101	0.000261	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MAOA—conduct disorder	0.000101	0.000261	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—EP300—conduct disorder	0.000101	0.000259	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—EP300—conduct disorder	0.0001	0.000258	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	9.83e-05	0.000253	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—EP300—conduct disorder	9.74e-05	0.000251	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—EP300—conduct disorder	9.36e-05	0.000241	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—EP300—conduct disorder	8.75e-05	0.000225	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—COMT—conduct disorder	7.88e-05	0.000203	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MAOA—conduct disorder	7.82e-05	0.000201	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—EP300—conduct disorder	7.27e-05	0.000187	CbGpPWpGaD
Imatinib—ALB—Metabolism—EP300—conduct disorder	6.26e-05	0.000161	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—EP300—conduct disorder	5.62e-05	0.000145	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—EP300—conduct disorder	5.48e-05	0.000141	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—EP300—conduct disorder	5.17e-05	0.000133	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—EP300—conduct disorder	5.12e-05	0.000132	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—EP300—conduct disorder	4.38e-05	0.000113	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—EP300—conduct disorder	3.38e-05	8.7e-05	CbGpPWpGaD
